Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical evaluation of an automated Alberta Stroke Program Early Computed Tomography Score (ASPECTS)-scoring system.

Quantitative imaging in medicine and surgery·2026
Same author

The degenerome-a novel streamline-wise approach for white matter integrity in neurodegeneration.

NPJ Parkinson's disease·2026
Same author

Characterization of meningeal diverticula in patients with cerebrospinal fluid-venous fistulas.

Journal of neurointerventional surgery·2026
Same author

Speech-Like Vibrotactile Stimulation Is Associated With Enhanced Cortical Activations in Single-Sided Deafness: An fMRI Study.

The European journal of neuroscience·2026
Same author

Real-world data on the impact of dose reduction measures on radiation exposure in CT perfusion of the brain.

European journal of radiology open·2026
Same author

Investigating adeno-associated virus stabilization at the air-water interface through competitive adsorption.

Journal of pharmaceutical sciences·2026
Same journal

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Endothelial injury with capillary leak: A final common pathway in acute AAV toxicity?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Nox1/4 inhibitor Setanaxib treatment ameliorates cardiac function in mouse models of Duchenne Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
See all related articles

Related Experiment Video

Updated: Dec 27, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.1K

Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening.

Kathleen Börner1, Eike Kienle2, Lin-Ya Huang3

  • 1Department of Infectious Diseases/Virology, BioQuant Center, Heidelberg University Hospital, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany; German Center for Infection Research (DZIF), Heidelberg, Germany.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|February 28, 2020
PubMed
Summary
This summary is machine-generated.

Researchers explored displaying peptides on various adeno-associated virus (AAV) capsids to create novel gene therapy vectors. This study identified superior AAV vectors for over 90 cell types, enhancing gene therapy development.

More Related Videos

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
13:49

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

11.9K
MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells
09:12

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells

Published on: December 21, 2011

19.0K

Related Experiment Videos

Last Updated: Dec 27, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.1K
Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
13:49

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

11.9K
MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells
09:12

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells

Published on: December 21, 2011

19.0K

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Displaying peptides on adeno-associated virus (AAV) surfaces is key for developing gene therapy vectors with improved cell targeting.
  • While AAV serotype 2 (AAV2) is well-studied, other AAV variants show promise as scaffolds for peptide display.

Purpose of the Study:

  • To systematically evaluate the potential of 13 different AAV capsid variants for displaying 27 peptides.
  • To identify superior AAV vectors for gene therapy applications across diverse cell types.

Main Methods:

  • Production of reporter-encoding AAV vectors with peptides inserted on capsid surfaces.
  • Single-round screening of vectors across more than 90 cell types, including T cells and primary cells.
  • Assembly of all experimental results into a searchable online database.

Main Results:

  • Identified superior AAV vectors by screening peptide insertions across multiple AAV capsids and cell types.
  • Demonstrated that vector performance is influenced by capsid type, peptide, cell type, insertion site, and flanking residues.
  • Established a high-throughput reverse-transduction pipeline for efficient library screening.

Conclusions:

  • Alternative AAV capsids offer vast potential for peptide display, accelerating the development of targeted gene therapy vectors.
  • The findings provide a comprehensive resource for selecting and engineering AAV vectors for specific in vivo applications.
  • This work facilitates the screening and application of novel AAV-based gene therapy tools.